FLAGSHIP HARBOR ADVISORS, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1691766
BOSTON, MA
Position in RXRX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$67,528
New position
Shares Held
18,400
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 58 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLAGSHIP HARBOR ADVISORS, LLC holds $2,839,268 across 7 Biotechnology names. RXRX ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,669 | $829,042 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
38,378 | $651,274 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
702 | $437,725 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,111 | $416,597 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
7,966 | $374,720 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
18,400 | $67,528 | |
| 7 | GERN |
Geron Corp
|
48,736 | $62,382 |
All Filings in RXRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,528 | 18,400 | Shares | Sole | 2026-07-22 | |
| No filing history on record for this holder in this stock. | ||||||